
|Articles|November 21, 2012
Company recalls skin treatment products
A compounding pharmacy at the center of a national outbreak of fungal meningitis has voluntarily recalled all of its products, including numerous drugs for treating skin conditions.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
KT-621 in Atopic Dermatitis: What Early EASI and Pruritus Data Show
2
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
3
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
4
What Dermatologists Need to Know About the First New Sunscreen Ingredient in Decades
5














